Journal of Clinical Pathology 2007;60:524-528
ORIGINAL ARTICLE
Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkins lymphomas with high rates of somatic hypermutation
1 Haemato-Oncology Laboratory, Belfast City Hospital, Belfast, Northern Ireland
2 Department of Haemato-Oncology, BLB, Institute of Cancer Research, Surrey, UK
3 Schools of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland
4 Biological Sciences, University of Ulster, Coleraine, Northern Ireland
5 Department of Histopathology, Royal Victoria Hospital, Belfast, Northern Ireland
Correspondence to:
Correspondence to:
Dr M A Catherwood
Haemato-Oncology Laboratory, Department of Haematology, Level C, Belfast City Hospital, Belfast BT9 7AB, Northern Ireland; mark.catherwood{at}bll.n-i.nhs.uk
Background: PCR detects clonal rearrangements of the Ig gene in lymphoproliferative disorders. False negativity occurs in germinal centre/post-germinal centre lymphomas (GC/PGCLs) as they display a high rate of somatic hypermutation (SHM), which causes primer mismatching when detecting Ig rearrangements by PCR.
Aims: To investigate the degree of SHM in a group of GC/PGCLs and assess the rate of false negativity when using BIOMED-2 PCR when compared with previously published strategies.
Methods: DNA was isolated from snap-frozen tissue from 49 patients with GC/PGCL (23 diffuse large B cell lymphomas (DLBCLs), 26 follicular lymphomas (FLs)) and PCR-amplified for complete (VDJH), incomplete (DJH) and Ig
/
rearrangements using the BIOMED-2 protocols, and compared with previously published methods using consensus primers. Germinal centre phenotype was defined by immunohistochemistry based on CD10, Bcl-6 and MUM-1.
Results: Clonality detection by amplifying Ig rearrangements using BIOMED-2 family-specific primers was considerably higher than that found using consensus primers (74% DLBCL and 96% FL vs 69% DLBCL and 73% FL). Addition of BIOMED-2 DJH rearrangements increased detection of clonality by 22% in DLBCL. SHM was present in VDJH rearrangements from all patients with DLBCL (median (range) 5.7% (2.513.5)) and FL (median (range) 5.3% (2.311.9)) with a clonal rearrangement.
Conclusions: Use of BIOMED-2 primers has significantly reduced the false negative rate associated with GC/PGCL when compared with consensus primers, and the inclusion of DJH rearrangements represents a potential complementary target for clonality assessment, as SHM is thought not to occur in these types of rearrangements.
Abbreviations: DLBCL, diffuse large B cell lymphoma; FL, follicular lymphoma; FR, framework; GC/PGCL, germinal centre/post-germinal centre lymphoma; SHM, somatic hypermutation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Bagg, A.
(2008). Malleable Immunoglobulin Genes and Hematopathology - The Good, the Bad, and the Ugly: A Paper from the 2007 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn.
10: 396-410
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
